Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO
RESEARCH TOOLSreports
ORGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.17 - $4.57
Previous CloseN/A
Volume97.61K
Average Volume (3M)470.35K
Market Cap
$458.90M
Enterprise Value$394.49M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.90
Next Earnings
Feb 27, 2025EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding125,725,800
10 Day Avg. Volume351,456
30 Day Avg. Volume470,346
Standard Deviation0.23
R-Squared0.17
Alpha-0.00152
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.06
Price to Cash Flow (P/CF)13.90
P/FCF Ratio19.80
Enterprise Value/Market Cap0.86
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.21
Enterprise Value/Ebitda64.06
Forecast
1Y Price Target
$4.00Price Target Upside18.34% Upside
Rating ConsensusHold
Number of Analyst Covering1
---
Organogenesis Holdings News
PremiumCompany Announcements
Organogenesis Holdings Secures $130M Investment for Growth
PremiumCompany Announcements
Organogenesis Reports Robust Third Quarter Growth
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ORGO FAQ
What was Organogenesis Holdings Inc’s price range in the past 12 months?
Organogenesis Holdings Inc lowest stock price was $2.17 and its highest was $4.57 in the past 12 months.
What is Organogenesis Holdings Inc’s market cap?
Organogenesis Holdings Inc’s market cap is $458.90M.
When is Organogenesis Holdings Inc’s upcoming earnings report date?
Organogenesis Holdings Inc’s upcoming earnings report date is Feb 27, 2025 which is in 6 days.
How were Organogenesis Holdings Inc’s earnings last quarter?
Organogenesis Holdings Inc released its earnings results on Nov 12, 2024. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of -$0.02 by $0.11.
Is Organogenesis Holdings Inc overvalued?
According to Wall Street analysts Organogenesis Holdings Inc’s price is currently Undervalued.
Does Organogenesis Holdings Inc pay dividends?
Organogenesis Holdings Inc does not currently pay dividends.
What is Organogenesis Holdings Inc’s EPS estimate?
Organogenesis Holdings Inc’s EPS estimate is -0.01.
How many shares outstanding does Organogenesis Holdings Inc have?
Organogenesis Holdings Inc has 125,725,800 shares outstanding.
What happened to Organogenesis Holdings Inc’s price movement after its last earnings report?
Organogenesis Holdings Inc reported an EPS of $0.09 in its last earnings report, beating expectations of -$0.02. Following the earnings report the stock price went up 28.406%.
Which hedge fund is a major shareholder of Organogenesis Holdings Inc?
Currently, no hedge funds are holding shares in ORGO
---
Organogenesis Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$4.00 (18.34% Upside)
$4.00 (18.34% Upside)
Blogger Sentiment
Bullish
ORGO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 31.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.43%
12-Months-Change
Fundamentals
Return on Equity
-2.66%
Trailing 12-Months
Asset Growth
-3.53%
Trailing 12-Months
Company Description
Organogenesis Holdings Inc
Organogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
---
ORGO Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance with revenue exceeding expectations and significant progress in clinical trials. However, challenges such as increased operating expenses and potential market disruptions were also discussed.Read More>---
ORGO Stock 12 Month Forecast
Average Price Target
$4.00
▲(18.34% Upside)
Technical Analysis
Best Analysts Covering ORGO
1 Year
1 Year Success Rate
7/27 ratings generated profit
1 Year Average Return
-19.93%
reiterated a buy rating 3 months ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 25.93% of your transactions generating a profit, with an average return of -19.93% per trade.
---